Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
Media
CBIS News Releases
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements
13-08-18
Cannabis Science Celebrates the Lives and Mourns the Loss of Dr. Allen Herman and The Honorable Ronald V. Dellums
08-08-18
Cannabis Science and FSO NAC Sign for New 100-Acre Property in Minden, Nevada as the Industrial Hemp Research Projects in Nevada Continue to Flourish for the Group
24-07-18
Cannabis Science Research Group FSO NAC / HRM Farms Receives Approvals From the Nevada Department of Agriculture for its Newest 40-Acre Industrial Hemp Research Project in Nevada
10-07-18
Cannabis Science, Harvard Medical School's Global Health Catalyst, Elpasso Farms (South Africa), and American States University Partner to Strengthen Africa's Economic and Healthcare Infrastructure
09-07-18
Cannabis Science’s University Scholarship Expo Begins This Weekend; Register Now at the Company’s Flagship Location: CBIS Cali Rx, 14006 Ventura Boulevard, Sherman Oaks, CA
08-06-18
Phase I Underway, Cannabis Science 1,000–Acre Elpasso Farms Economic Development Plan in South Africa; Agriculture, Food Security, Phytomedicines, with an Emphasis on Micro-Nutrients, and Education
05-06-18
Cannabis Science CEO Receives Prestigious Industry Leader Award at 2018 Global Health Catalyst Summit at Harvard Medical School and Announces Major Collaboration With Elpasso Farms in South Africa
29-05-18
2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives Present Live
25-05-18
Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst Industry Leader Award May 25-27th at Harvard Medical School, Boston, MA
14-05-18
Cannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of Cancers
01-05-18
Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’
27-04-18
Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers
02-02-18
Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines
31-01-18
Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings
29-01-18
Start
Prev
1
2
3
4
Next
End